Journal Radiotherapy and Clinical Oncology (Radiother Clin Oncol) (ISSN 2674-2497)

Aims and Scope

Radiotherapy and Clinical Oncology is a peer reviewed, open access journal encompassing all aspects of research that impacts on the treatment of cancer using radiation. The journal publishes articles in molecular and cellular radiation biology, radiation physics, radiation technology, clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology and clinical oncology.

Radiotherapy and Clinical Oncology provides an open access forum for researchers and clinicians involved in the management and treatment of cancer patients, bringing together the latest advances and research. The integration of radiation therapy into multimodal treatment approaches is covered by the field of radiation oncology. The journal focusses in presenting original research findings for generating relevant case stories and critical reviews and for stimulating commentaries and professional debates in Letters to the Editor.

All the work at Science Repository is licensed under a Creative Commons Attribution 4.0 International License. Authors at Science Repository retain copyright to their work and allow others to copy, distribute, transmit, and adapt their work, provided proper attribution is given. Electronic edition: online edition: ISSN 2674-2497

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. View License Deed | View Legal Code

For submission authors can directly submit manuscript to


Manuscripts number will be provided to the corresponding author within 72 hours for the respective manuscript submitted.

  • 14 day review process with international peer-review standards
  • Timeline of processing from Submission to Publication is 30 days
  • Manuscript will be published within 7 days of acceptance




Department of Nuclear Medicine and PET Unit

Rovigo Hospital



Dr. Domenico Rubello is Professor of Nuclear Medicine in Oncology and Positron Emission Tomography (PET) at the Post-graduate Radiotherapy and Oncology Medical School at Padova University and Nuclear Medicine in Radio-guided Surgery at the Post-graduate Surgery Medical School at Padova University. He is Head of the Nuclear Medicine Service, PET/CT Centre at Rovigo General Hospital in Veneto (Italy).He is Director of the Department of Imaging (Radiology, Medical Physics, Nuclear Medicine and PET/CT Centre) at Rovigo General Hospital in Veneto (Italy). He is/has been member of various scientific Societies (American Society of Nuclear Medicine-SNM, European Association of Nuclear Medicine-EANM, Italian Association of Nuclear Medicine-AIMN, Italian Study Group on Radioguided Surgery-GISCRIS and so forth). He has been Chair of the Parathyroid Study Group of the Italian Association of Nuclear Medicine-AIMN from 2000 to 2008. He is author of more than 1000 scientific papers, 349 of them cited in PubMed/MEDLINE (other 8 accepted full papers for publication will appear shortly in PubMed/MEDLINE) and 27 Textbooks or Chapters of Textbooks in Nuclear Medicine, Radio-guided surgery, PET and Oncology. The reasearch interest of Dr. Domenico Rubello include PET/CT experimental research in animals and in humans, small animal PET, Nuclear medicine and radiology animal study (rat and monkey).

Editorial board

Mandip Singh Sachdeva


Florida A&M University


Domenico Rubello


Department of Nuclear Medicine and PET Unit

Rovigo Hospital


Vandana Rai


VBS Purvanchal University


LEUNG Ping Chung

Honorary Advisers

Hong Kong Society for Surgery of the Hand (HKSSH)

Hong Kong

Thaiz Ferraz Borin

Assistant Research Scientist

Department of Biochemistry and Molecular Biology

Augusta University


Mohammad Hasanzadeh

Assistant Professor

Drug Applied Research Center Tabriz University of Medical Sciences


Aamir Ahmad


Karmanos Cancer Institute

Wayne State University


Cynthia Xiuguang Ma

Associate Professor

Division of Oncology

Washington University School of Medicine


Rodrigo R. Munhoz

Medical Oncologist

Universidade de Sao Paulo


Qamruzzaman Chowdhury

Director Medical Services &Head

Department of Radiation Oncology

Ahsania Mission Cancer & General Hospital

Dr. Ramadevi Subramani Reddy

Post-Doctoral Research Associate

Texas Tech University Health Sciences Center


Shuen-Kuei Liao

Taipei Medical University


D Raghunadharao

Homi Bhabha Cancer Hospital & Research Centre


Prerna Mewawalla

Hematology and Stem Cell Transplant Physician

West Penn Hospital


Ling Gao

Associate Professor

supervisor of master Department of Radiobiology

National Insitute for Radiological Protection


A. Heidari

Faculty of Chemistry

California Southern University

California, USA

Chi-Yu Gregory Lee


Obstetrics and Gynaecology

The University of British Columbia


Douglas P. Malinowski

BD Fellow

Global Head of Scientific Affairs

Chief Scientific Officer

BD Diagnostics Women’s Health and Cancer


Nahum J. Duker


Department of Pathology and Laboratory Medicine

Fels Institute for Cancer Research and Molecular Biology

Temple University


T. Manikandan

Associate Professor

Department of Electronics & Communication Engineering

Rajalakshmi Engineering College

Thandalam, Chennai


Submit Manuscript

You can submit your manuscript at Science Repository. Authors submit manuscript files and metadata & can request for revision. Editors use the system to review submissions, assign to reviewers, and make and communicate decisions to accept, revise, transfer or reject manuscripts. Reviewers are invited to work on manuscripts, can accept or reject assignments.

For submission authors can directly submit manuscript to

Manuscripts number will be provided to the corresponding author within 72 hours for the respective manuscript submitted.

  • 14 day review process with international peer-review standards
  • Timeline of processing from Submission to Publication is 30 days
  • Manuscript will be published within 7 days of acceptance

Publication Charges

Radiotherapy and Clinical Oncology is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License".

In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Radiotherapy and Clinical Oncology are £ (GBP) 1099.

Frequently Asked Questions (FAQs)

Why do we charge?

All articles published in Science Repository are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in Science Repository Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Maintain the portal for best experienece
  • Recover capitalization cost
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development
  • Although we charge the minimum possible but we will reduce the publication-charge cost downward over time.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

Who will pay the APC (Article Processing Charges)?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  • Online Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction gateway charges may be levied on the payee.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after processing of the manuscript.

Withdrawal Charges

Please check our Refund Policy

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

For more details you can refer to FAQs or contact us